Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow in Hematology and Oncology, Medicine, Icahn School of Medicine at Mount Sinai 2004 - 2007
  • Medical Resident, Medicine, Icahn School of Medicine at Mount Sinai 2001 - 2004
  • M.D., University of Medicine and Dentistry of New Jersey 2001
• 

  Duke Appointment History

  • Assistant Professor of Medicine, Medicine, Medical Oncology, Medicine 2007 - 2013
  • Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 2007
• Research
• 

  Selected Grants

  • PROSPECTIVE, LONGITUDINAL, NON-INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW-RISK MYELOFIBROSIS (MF) OR HIGH-RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET-DIRECTED THERAPY awarded by Incyte Corporation 2017 - 2027
  • A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia awarded by Rigel Inc 2019 - 2024
  • Protocol A5481082: POLARIS awarded by Pfizer, Inc. 2017 - 2022
  • Treatment Resistance Following Anti-Cancer Therapies (TRANSLATE) awarded by Pfizer, Inc. 2019 - 2020
  • REVEAL: Prospective, Non-interventional Study of Disease Progression and Treatment of Patients with Polycythemia Vera in United States Academic or Community Clinical Practices awarded by Incyte Corporation 2014 - 2020
• 

  External Relationships

  • Amgen, Inc.
  • Dova
  • Novartis
  • Pfizer Inc.
  • incyte
  • rigel inc
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Strickler, John H., Christel N. Rushing, Donna Niedzwiecki, Abigail McLeod, Ivy Altomare, Hope E. Uronis, S David Hsu, et al. “A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer.” Bmc Cancer 19, no. 1 (November 1, 2019): 1032. https://doi.org/10.1186/s12885-019-6234-8.
       Full Text  Link to Item
    • Zullig, Leah L., Gretchen Kimmick, Valerie Smith, Katie Little, Hayden B. Bosworth, Sarah Gonzales, Megan M. Oakes, Rebecca A. Shelby, Lynda Owen, and Ivy P. Altomare. “Using a geriatric oncology assessment to link with services (GOAL).” J Geriatr Oncol 10, no. 1 (January 2019): 164–68. https://doi.org/10.1016/j.jgo.2018.06.004.
       Full Text  Link to Item
    • Chino, Fumiko, Jeffrey M. Peppercorn, Christel Rushing, Jonathan Nicolla, Arif H. Kamal, Ivy Altomare, Greg Samsa, and S Yousuf Zafar. “Going for Broke: A Longitudinal Study of Patient-Reported Financial Sacrifice in Cancer Care.” J Oncol Pract 14, no. 9 (September 2018): e533–46. https://doi.org/10.1200/JOP.18.00112.
       Full Text  Link to Item
    • Li, Shuling, Julia T. Molony, Karynsa Cetin, Jeffrey S. Wasser, and Ivy Altomare. “Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study.” Curr Med Res Opin 34, no. 2 (February 2018): 209–16. https://doi.org/10.1080/03007995.2017.1360852.
       Full Text  Link to Item
    • Chino, Fumiko, Jeffrey M. Peppercorn, Christel Rushing, Arif H. Kamal, Ivy Altomare, Greg Samsa, and S Yousuf Zafar. “Out-of-Pocket Costs, Financial Distress, and Underinsurance in Cancer Care.” Jama Oncology 3, no. 11 (November 2017): 1582–84. https://doi.org/10.1001/jamaoncol.2017.2148.
       Full Text
    • Lin, Junji, Xinke Zhang, Xiaoyan Li, David Chandler, Ivy Altomare, Jeffrey S. Wasser, and Karynsa Cetin. “Cost of Bleeding-related Episodes in Adult Patients With Primary Immune Thrombocytopenia: A Population-based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States.” Clin Ther 39, no. 3 (March 2017): 603-609.e1. https://doi.org/10.1016/j.clinthera.2017.01.023.
       Full Text  Link to Item
    • Altomare, I., K. Cetin, S. Wetten, and J. S. Wasser. “Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: A retrospective cohort study using a large administrative medical claims database in the US.” Clinical Epidemiology 8 (June 20, 2016): 231–39. https://doi.org/10.2147/CLEP.S105888.
       Full Text
    • Altomare, Ivy, Blair Irwin, Syed Yousuf Zafar, Kevin Houck, Bailey Maloney, Rachel Greenup, and Jeffrey Peppercorn. “Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care.” J Oncol Pract 12, no. 3 (March 2016): e281-248. https://doi.org/10.1200/JOP.2015.007401.
       Full Text  Link to Item
    • Cines, Douglas B., Terry Gernsheimer, Jeffrey Wasser, Bertrand Godeau, Drew Provan, Roger Lyons, Ivy Altomare, Xuena Wang, and Angela Lopez. “Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.” Int J Hematol 102, no. 3 (September 2015): 259–70. https://doi.org/10.1007/s12185-015-1837-6.
       Full Text  Link to Item
    • Zafar, S Yousuf, Fumiko Chino, Peter A. Ubel, Christel Rushing, Gregory Samsa, Ivy Altomare, Jonathan Nicolla, et al. “The utility of cost discussions between patients with cancer and oncologists.” Am J Manag Care 21, no. 9 (September 2015): 607–15.
       Link to Item
    • Liu, Yingmiao, Mark D. Starr, John C. Brady, Christel Rushing, Anuradha Bulusu, Herbert Pang, Wanda Honeycutt, et al. “Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus.” Mol Cancer Ther 14, no. 4 (April 2015): 1048–56. https://doi.org/10.1158/1535-7163.MCT-14-0923-T.
       Full Text  Link to Item
    • Nussbaum, Nathan, and Ivy Altomare. “The neoadjuvant treatment of rectal cancer: a review.” Curr Oncol Rep 17, no. 3 (March 2015): 434. https://doi.org/10.1007/s11912-014-0434-9.
       Full Text  Link to Item
    • Selleslag, Dominik, Robert Bird, Ivy Altomare, Aristoteles Giagounidis, Ann Janssens, Ingrid Pabinger, Vinod Pullarkat, Helen Wei, and Georg Kreuzbauer. “Impact of self-administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider.” Eur J Haematol 94, no. 2 (February 2015): 169–76. https://doi.org/10.1111/ejh.12415.
       Full Text  Link to Item
    • Bestvina, Christine M., Leah L. Zullig, Christel Rushing, Fumiko Chino, Gregory P. Samsa, Ivy Altomare, James Tulsky, et al. “Patient-oncologist cost communication, financial distress, and medication adherence.” J Oncol Pract 10, no. 3 (May 2014): 162–67. https://doi.org/10.1200/JOP.2014.001406.
       Full Text  Link to Item
    • Showalter, K., J. Maize, I. Altomare, and G. Fisher. “Multiple myeloma diagnosed secondary to analysis of a lytic bone lesion encountered during mohs micrographic surgery.” Dermatology Online Journal 19, no. 8 (August 21, 2013).
    • Showalter, Kimberly, John Maize, Ivy Altomare, and Galen Fisher. “Multiple myeloma diagnosed secondary to analysis of a lytic bone lesion encountered during Mohs micrographic surgery.” Dermatol Online J 19, no. 8 (August 15, 2013): 19262.
       Link to Item
    • Altomare, Ivy, and Herbert Hurwitz. “Everolimus in colorectal cancer.” Expert Opin Pharmacother 14, no. 4 (March 2013): 505–13. https://doi.org/10.1517/14656566.2013.770473.
       Full Text  Link to Item
    • Uronis, Hope E., Johanna C. Bendell, Ivy Altomare, Gerard C. Blobe, S David Hsu, Michael A. Morse, Herbert Pang, et al. “A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.” Oncologist 18, no. 3 (2013): 271–72. https://doi.org/10.1634/theoncologist.2012-0404.
       Full Text  Link to Item
    • Altomare, Ivy, Jeffrey Wasser, and Vinod Pullarkat. “Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data.” Am J Hematol 87, no. 10 (October 2012): 984–87. https://doi.org/10.1002/ajh.23275.
       Full Text  Link to Item
    • Altomare, Ivy, Johanna C. Bendell, Karen E. Bullock, Hope E. Uronis, Michael A. Morse, S David Hsu, S Yousuf Zafar, et al. “A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer.” Oncologist 16, no. 8 (2011): 1131–37. https://doi.org/10.1634/theoncologist.2011-0078.
       Full Text  Link to Item
    • Hilari, Josep M., Cristina Mangas, Liqiang Xi, Cristina Paradelo, Carlos Ferrándiz, Steven J. Hughes, Cindy Yueh, Ivy Altomare, William E. Gooding, and Tony E. Godfrey. “Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.” Ann Surg Oncol 16, no. 1 (January 2009): 177–85. https://doi.org/10.1245/s10434-008-0183-9.
       Full Text  Link to Item
    • Altomare, I., A. Adler, and L. M. Aledort. “The 5, 10 methylenetetrahydrofolate reductase C677T mutation and risk of fetal loss: A case series and review of the literature.” Thrombosis Journal 5 (October 17, 2007). https://doi.org/10.1186/1477-9560-5-17.
       Full Text
    • Altomare, Ivy, Garrett Desman, and Louis M. Aledort. “Echinocytosis--an unusual manifestation of hemangioma.” Am J Hematol 81, no. 7 (July 2006): 532–34. https://doi.org/10.1002/ajh.20558.
       Full Text  Link to Item
    • Lapointe, R., R. E. Royal, M. E. Reeves, I. Altomare, P. F. Robbins, and P. Hwu. “Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100.” J Immunol 167, no. 8 (October 15, 2001): 4758–64. https://doi.org/10.4049/jimmunol.167.8.4758.
       Full Text  Link to Item

  • Conference Papers

    • McGrath, Leah J., Karynsa Kilpatrick, Robert A. Overman, Diane Reams, Anjali Sharma, Ivy Altomare, Jeffrey Wasser, and M Alan Brookhart. “Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States.” In Clinical Epidemiology, 12:435–45, 2020. https://doi.org/10.2147/clep.s229266.
       Full Text
    • Irwin, Blair, Gretchen Kimmick, Ivy Altomare, P Kelly Marcom, Kevin Houck, S Yousuf Zafar, and Jeffrey Peppercorn. “Patient experience and attitudes toward addressing the cost of breast cancer care.” In The Oncologist, 19:1135–40, 2014. https://doi.org/10.1634/theoncologist.2014-0117.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.